InsiderTrades

Form 4 for CELU Celularity Inc

Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-17 · accession 0001493152-25-007614 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-19 2025-02-17 CELU Brigido Stephen Pres, Functional Regeneration F - Tax $2.14 -3,272 8,369 -28% -$7,002
D 2025-02-19 2025-02-17 CELU Brigido Stephen Pres, Functional Regeneration M - OptEx $0.00 +10.0K 11.6K +609% $0
D 2025-02-19 2025-02-17 CELU Brigido Stephen Pres, Functional Regeneration M - OptEx $0.00 -10.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-02-17 F D 3,272 $2.14 8,369 D — —
2 Common Class A Common Stock 2025-02-17 M A 10,000 $0.00 11,641 D — —
3 Derivative Restricted Stock Units 2025-02-17 M D 10,000 $0.00 0 D — · — to — 10,000 Class A Common Stock (F3) Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. (F4) On February 17, 2023, the reporting person was granted 10,000 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4.